Regulating macrophage phenotypes with IL4I1-mimetic nanoparticles in IDD treatment

Area of Science:

• Biomaterials Science
• Immunology
• Nanotechnology

Background:

• Intervertebral disc degeneration (IDD) is a debilitating spinal condition causing pain and reduced quality of life.
• Current treatments for IDD often involve long-term medication or invasive procedures.

Purpose of the Study:

• To develop a novel therapeutic strategy for IDD using a cellulose supramolecular hydrogel.
• To investigate the efficacy of IL4I1-modified MΦ membrane biomimetic nanoparticles (CHG@IL4I1-MNPs) in treating IDD.

Main Methods:

• Utilized cellulose supramolecular hydrogel as a carrier for sustained drug release.
• Engineered IL4I1-modified MΦ membrane biomimetic nanoparticles for targeted delivery.
• Evaluated the immunomodulatory effects on macrophage polarization (M2 activation).
• Conducted animal studies to assess therapeutic outcomes in IDD models.

Main Results:

• The hydrogel demonstrated biocompatibility and sustained release properties.
• CHG@IL4I1-MNPs effectively promoted M2 macrophage polarization, rebalancing the immune microenvironment.
• Animal studies showed alleviation of IDD symptoms, reduced inflammation, and enhanced tissue repair.
• The strategy achieved precise targeting of macrophages through combined nanotechnology and immunomodulation.

Conclusions:

• The CHG@IL4I1-MNP strategy offers a promising, innovative treatment for IDD.
• This approach has the potential to reduce reliance on long-term medication and improve patient quality of life.
• The versatile platform shows potential for treating other immune-related diseases beyond IDD.